Skip to content

Opening book details…

About this Medicine article

A Phase 3, open-label, non-comparative study of tigecycline in the treatment of patients with selected serious infections due to resistant Gram-negative organisms including Enterobacter species, Acinetobacter baumannii and Klebsiella pneumoniae by Vasilev, K.; Reshedko, G.; Orasan, R.; Sanchez, M.; Teras, J.; Babinchak, T.; Dukart, G.; Cooper, A.; Dartois, N.; Gandjini, H.; Orrico, R.; Ellis-Grosse, E. is a Medicine article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Medicine.

Author
Vasilev, K.; Reshedko, G.; Orasan, R.; Sanchez, M.; Teras, J.; Babinchak, T.; Dukart, G.; Cooper, A.; Dartois, N.; Gandjini, H.; Orrico, R.; Ellis-Grosse, E.
Publisher
Oxford University Press; Oxford University Press (OUP) (ISSN 0305-7453)
Published
2008
Field
Medicine (Health Sciences)

More by Vasilev, K.; Reshedko, G.; Orasan, R.; Sanchez, M.; Teras, J.; Babinchak, T.; Dukart, G.; Cooper, A.; Dartois, N.; Gandjini, H.; Orrico, R.; Ellis-Grosse, E.

Browse all works by Vasilev, K.; Reshedko, G.; Orasan, R.; Sanchez, M.; Teras, J.; Babinchak, T.; Dukart, G.; Cooper, A.; Dartois, N.; Gandjini, H.; Orrico, R.; Ellis-Grosse, E.